Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834
Q3 FY23 results · Oct–Dec 2022
Camlin Fine Sciences reported revenue from operations of ₹387.84 crore (up 1.8% from Q3 FY22) and net profit of ₹22.86 crore (down 15.8% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 387.84 | 380.82 | +1.8% | 483.25 | −19.7% |
| Other income | 9.76 | 5.58 | +74.9% | 2.88 | +239.5% |
| Total income | 397.60 | 386.40 | +2.9% | 486.12 | −18.2% |
| Profit before tax | 31.79 | 40.69 | −21.9% | 25.61 | +24.1% |
| Net profit for the period | 22.86 | 27.15 | −15.8% | 9.87 | +131.6% |
| Attributable to shareholders of the company | 24.04 | — | — | 13.02 | +84.7% |
| EPS, basic (₹) | 1.53 | 2.25 | not comparable | 0.83 | +84.3% |
| Net margin (%) | 5.9 | 7.1 | 2.0 |
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 172.69 | 200.22 | −13.8% | 243.15 | −29.0% |
| Other income | 11.02 | 7.25 | +52.0% | 12.10 | −8.9% |
| Total income | 183.71 | 207.47 | −11.5% | 255.25 | −28.0% |
| Profit before tax | 19.34 | 17.21 | +12.4% | 30.69 | −37.0% |
| Net profit for the period | 15.79 | 12.38 | +27.6% | 18.68 | −15.5% |
| EPS, basic (₹) | 1.01 | 0.97 | not comparable | 1.19 | −15.1% |
| Net margin (%) | 9.1 | 6.2 | 7.7 |
Consolidated
- Filed with BSE
- 16 Feb 2023, 15:33 IST
- Board meeting
- 13 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 16 Feb 2023, 15:33 IST
- Board meeting
- 13 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE